{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:14:10Z","timestamp":1775632450154,"version":"3.50.1"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              Although the article by J C\u00e0mara, I Grau, A Gonz\u00e1lez-D\u00edaz, N Santos, et al. (Antimicrob Agents Chemother 69:e00237-25, 2025,\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1128\/mBio.00829-13)\" xlink:type=\"simple\"\/>\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1128\/aac.00237-25\" xlink:type=\"simple\">https:\/\/doi.org\/10.1128\/aac.00237-25<\/jats:ext-link>\n              ) suggests that ceftriaxone is greatly superior to amoxicillin in treating pneumonia due to pneumococci with an MIC &gt; 2 mg\/L, much of the difference in efficacy of the two drugs may have been due to dosage, route, and times of administration of the amoxicillin.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/aac.00780-25","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T14:05:12Z","timestamp":1755093912000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Amoxicillin vs. ceftriaxone to treat pneumonia caused by amoxicillin-non-susceptible\n            <i>Streptococcus pneumoniae<\/i>"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-066X","authenticated-orcid":true,"given":"Daniel M.","family":"Musher","sequence":"first","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine","place":["Houston, USA"]},{"name":"Department of Microbiology and Molecular Virology, Baylor College of Medicine","place":["Houston, USA"]},{"name":"Medical Care Line (Infectious Disease Section), Michael E. DeBakey Veterans Affairs Medical Center","place":["Houston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)87996-9"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)72122-2"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM194506282322601"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.103.2678.501"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5817.13"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)92892-6"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200003000-00003"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209165"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00237-25"},{"key":"e_1_3_1_11_2","volume-title":"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics","author":"Musher D","year":"2021","unstructured":"Musher D. 2021. Resistance of Streptococcus pneumoniae to beta-lactam antibiotics. UpToDate, Waltham, MA."},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.21.2538"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw226"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku195"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00780-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00780-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:02:25Z","timestamp":1756904545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00780-25"}},"subtitle":[],"editor":[{"given":"Cesar A.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,3]]}},"alternative-id":["10.1128\/aac.00780-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.00780-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"2025-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00780-25"}}